A F O U N D AT I O N f o r

Size: px
Start display at page:

Download "A F O U N D AT I O N f o r"

Transcription

1

2 A F O U N D AT I O N f o r Because ATOPIC DERMATITIS is one of the most prevalent skin diseases Because it significantly alters the quality of life of millions of children and their families Because a great deal of research work is still required to solve all its mysteries Pierre Fabre Laboratories have decided to seek even closer relations between scientists, doctors, patients and their families by creating a corporate foundation exclusively dedicated to ATOPIC DERMATITIS. A FOUNDATION for Research The teams involved in research on ATOPIC DERMATITIS, whether epidemiology, genetics, immunology, fundamental or clinical research, may apply to the FOUNDATION for material support subject to approval by the Foundation s Scientific Committee. A FOUNDATION for Information ATOPIC DERMATITIS is not well known. Parents, as well as educators, doctors and other healthcare professionals, need information on the nature of ATOPIC DERMATITIS, its treatments, impact on the life of patients and their families, and the best ways to relieve the burden this disease creates. The FOUNDATION will contribute to the distribution of this information through professional and general media.

3 Missions Participate in financing research and clinical studies on ATOPIC DERMATITIS. Support all activities, whether scientific or media-based, to better communicate and provide information on the disease, therapeutic treatments and the daily life of patients. Design and implement educational tools and actions. Create, publish and distribute information materials for practitioners, parents and children.

4 Projects Participation in the creation of the Schools of Atopy in Madrid, Milan, Cracow, Gdansk, Rome and Buenos Aires. Creation of educational tools and brochures on therapeutic education. Support in the creation of an internet site for exchanges between professors on therapeutic education related to ATOPIC DERMATITIS (Opened Dermatology). Implementation of a European exchange bursary to reward scientific projects on ATOPIC DERMATITIS conducted within a hospital.

5 A FOUNDATION for Education To participate in this effort, Pierre Fabre Laboratories have decided to create a corporate FOUNDATION, the objective of which is to support research projects in any field that may improve our understanding of ATOPIC DERMATITIS and its treatment. Like all chronic diseases, ATOPIC DERMATITIS is difficult to treat. Children and parents who do not always know how to take advantage of available treatments with their benefits, but also limitations, often become discouraged. Therapeutic education uses appropriate tools to provide the knowledge required, which can be immediately transformed into precious know-how to be applied in everyday life. Schools of Atopy, already in existence, have acquired experience that the Foundation will help communicate. A FOUNDATION for you If ATOPIC DERMATITIS is a concern for you, the FOUNDATION is at your service. Whether a researcher, doctor, healthcare professional, educator, patient or group of patients, the FOUNDATION will be your attentive partner.

6 FOUNDATION for ATOPIC DERMATITIS: Research and education If you would like to invest in the field of ATOPIC DERMATITIS or further fundamental or clinical research; if you would like to participate in all the efforts in place to improve the quality of life and treatment of patients suffering from ATOPIC DERMATITIS. Scientific Committee Professor Carle Paul (Hôpital Purpan - Toulouse) Professor Jean-François Nicolas (Centre Hospitalier - Lyon Sud) Professor Jean-François Stalder (Hôtel Dieu - Nantes) Contact us: fondationdermatiteatopique@pierre-fabre.com Founding companies Pierre Fabre Dermocosmétique Pierre Fabre Médicament Pierre Fabre Dermatologie Laboratoires Dermatologiques Ducray Laboratoires Dermatologiques Avène Laboratoires Klorane Laboratoires Boiron FONDATION POUR LA DERMATITE ATOPIQUE - RECHERCHE ET ÉDUCATION Hôtel-Dieu Saint Jacques - 2, rue Viguerie TOULOUSE - Tél : 33 (5)

Nocera T (1,2), Lapalud P (1), Touitou K (3), Rossi AB (1,2) INTRODUCTION

Nocera T (1,2), Lapalud P (1), Touitou K (3), Rossi AB (1,2) INTRODUCTION Clinical and instrumental efficacy and tolerability of a dermo-cosmetic depigmenting and anti-aging night care on reducing actinic lentigo and wrinkles Nocera T (1,2), Lapalud P (1), Touitou K (3), Rossi

More information

SCORAD and PO-SCORAD

SCORAD and PO-SCORAD SCORAD and PO-SCORAD Tools for assessing atopic eczema MetteDeleuran Department of Dermatology Aarhus University Hospital, Denmark SCORAD and PO-SCORAD Tools for assessing atopic eczema SCORAD: The doctors

More information

INTRODUCTION. EADV 2015 poster 1044 (Pigmentary disease)

INTRODUCTION. EADV 2015 poster 1044 (Pigmentary disease) Clinical and instrumental efficacy and tolerability of a dermocosmetic anti-aging and depigmenting serum on reducing actinic lentigo and wrinkles Nocera T (1,2), Lapalud P (1), Touitou K (3), Rossi AB

More information

SUPPLEMENTARY DATA. Telediab Study Group :

SUPPLEMENTARY DATA. Telediab Study Group : Telediab Study Group : Guillaume Charpentier, MD, Department of Diabetes, Sud-Francilien Hospital, Corbeil-Essonnes, France Centre d Études et de Recherches pour l Intensification du Traitement du Diabète

More information

THE EUROPEAN SPINE CENTER

THE EUROPEAN SPINE CENTER THE EUROPEAN SPINE CENTER Created in 1987 by Charles Picault, Jean Claude de Mauroy and Jean Jacques Lalain, Spine Center of Lyons pursues the big tradition of the Orthopaedics of Lyons in the field of

More information

EVALUATION OF THERAPEUTIC PROGRAMS EDUCATING AD PATIENTS AND THEIR PARENTS

EVALUATION OF THERAPEUTIC PROGRAMS EDUCATING AD PATIENTS AND THEIR PARENTS EVALUATION OF THERAPEUTIC PROGRAMS EDUCATING AD PATIENTS AND THEIR PARENTS Rencontres 2èmes Internationales sur l Él Éducation Thérapeutique dans la Dermatite Atopique Rome, le 1er juillet 2011 Danielle

More information

Accepted Manuscript. Building a scale for measuring burden of hand eczema: BoHEM

Accepted Manuscript. Building a scale for measuring burden of hand eczema: BoHEM Accepted Manuscript Building a scale for measuring burden of hand eczema: BoHEM François Maccari, MD, Khaled Ezzedine, MD, Anne Claire Fougerousse, MD, Stéphanie Mérhand, PhD, Charles Bordet, MSc, Caroline

More information

RIC-Mel Network - Network for Research and Clinical Investigation on Melanoma - French national cohort of

RIC-Mel Network - Network for Research and Clinical Investigation on Melanoma - French national cohort of RIC-Mel Network - Network for Research and Clinical Investigation on Melanoma - French national cohort of melanoma patients Head : Pr Dreno Brigitte, INSERM Unité U892 Equipe 2 «Recherche clinique et translationnelle

More information

Protocol for core outcomes consensus meeting- HOME V

Protocol for core outcomes consensus meeting- HOME V Protocol for core outcomes consensus meeting- HOME V Title: HOME V meeting Date: 1pm, Monday 12 th June 2017 1pm Wednesday 14 th June 2017 Venue: CCI Nantes, Nantes, France Date of protocol: 15 th May

More information

Pathophysiology of autoimmune and allergic diseases. Hypersensitivity reactions type II type IV

Pathophysiology of autoimmune and allergic diseases. Hypersensitivity reactions type II type IV Pathophysiology of autoimmune and allergic diseases Hypersensitivity reactions type II type IV Audrey NOSBAUM, Florence HACARD, Marc VOCANSON, Frédéric BERARD, Jean François NICOLAS Allergologie et Immunologie

More information

27-28 November, 2017 Paris, France Espace Saint-Martin

27-28 November, 2017 Paris, France Espace Saint-Martin 27-28 November, 2017 Paris, France Espace Saint-Martin 199 bis rue Saint-Martin, 75003 Paris Immuno-oncology research and the subsequent development of immunotherapies continue to progress rapidly. We

More information

For personal use only

For personal use only Australian Securities Exchange Limited Companies Announcements Office SYDNEY 4 April, 2012 New Australian Drug Developer Lists on ASX Key points Growth-focused Australian drug and therapeutic development

More information

A national perspective: the French case

A national perspective: the French case INNOVATIVE SOLUTIONS FOR RESEARCH IN HEALTHCARE Developing a novel approach to deliver better precision medicine in Europe SESSION II: ROLE OF GOVERNAMENTAL & REGULATORY BODIES A national perspective:

More information

9th IAS Conference on HIV Science (IAS 2017), July 23-26, 2017, Paris. Mark Mascolini

9th IAS Conference on HIV Science (IAS 2017), July 23-26, 2017, Paris. Mark Mascolini Maintenance With Raltegravir/Etravirine Strong at 48 Weeks in Older Adults - Efficacy of a Maintenance Strategy with Raltegravir/Etravirine : the ANRS 163 ETRAL trial 9th IAS Conference on HIV Science

More information

2016 Half-Year Results Solid cash position of 33 million and major scientific results

2016 Half-Year Results Solid cash position of 33 million and major scientific results Press release 2016 Half-Year Results Solid cash position of 33 million and major scientific results Toulouse, FRANCE, Ann Arbor, UNITED STATES, September 5, 2016 Cerenis Therapeutics (FR0012616852 - CEREN),

More information

The European Dermatology Forum (EDF)

The European Dermatology Forum (EDF) The European Dermatology Forum (EDF) A non-profit professional organization dedicated to improving the quality of healthcare for Dermatology patients in Europe www.euroderm.org European Dermatology Forum

More information

Cancer Biology and Immunology. Sponsorship CANCER BIOLOGY rd World Congress on. Don t count the days make the Days Count

Cancer Biology and Immunology. Sponsorship CANCER BIOLOGY rd World Congress on. Don t count the days make the Days Count CANCER BIOLOGY 2019 Sponsorship March 11-12, 2019 Milan, Italy 3 rd World Congress on Cancer Biology and Immunology Don t count the days make the Days Count http://cancerbiology.immunologycongress.org/

More information

Emergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011.

Emergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011. Emergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011. Sophie Vaux, Anne Carbonne, Jean-Michel Thiolet, Vincent Jarlier, Bruno Coignard, the RAISIN and Expert Laboratories Group

More information

Interna'onal congress on Cancer cell death and resistance

Interna'onal congress on Cancer cell death and resistance ! Interna'onal congress on Cancer cell death and resistance May 6 and 7, 2013 h"p://kcelldeath.sciencesconf.org Golf of Seilh Near to Toulouse (Midi-Pyrénées, 31, France) Introduction Content : ² Introduction

More information

Assessment of Quality of Life Using Skindex-16 in Patients With Locally Advanced Basal Cell Carcinoma Treated With Vismodegib in the STEVIE Study

Assessment of Quality of Life Using Skindex-16 in Patients With Locally Advanced Basal Cell Carcinoma Treated With Vismodegib in the STEVIE Study Assessment of Quality of Life Using Skindex-16 in Patients With Locally Advanced Basal Cell Carcinoma Treated With Vismodegib in the STEVIE Study Jean-Jacques Grob, 1 Karen Bartley, 2 Rainer Kunstfeld,

More information

AUSTRALIA S FIRST DEDICATED DEPARTMENT OF DIABETES. med.monash.edu/cecs/diabetes

AUSTRALIA S FIRST DEDICATED DEPARTMENT OF DIABETES. med.monash.edu/cecs/diabetes AUSTRALIA S FIRST DEDICATED DEPARTMENT OF DIABETES med.monash.edu/cecs/diabetes 2 MONASH UNIVERSITY DEPARTMENT OF DIABETES AT A GLANCE FAST FACTS WHO WE ARE Monash University s Department of Diabetes is

More information

The Cochrane Skin Group - Core Outcome Set Initiative to develop core outcome sets across the whole of dermatology

The Cochrane Skin Group - Core Outcome Set Initiative to develop core outcome sets across the whole of dermatology The Cochrane Skin Group - Core Outcome Set Initiative to develop core outcome sets across the whole of dermatology Jan Kottner On behalf of the CSG-COUSIN 1 Background I Non-comparable outcome measures

More information

Boiron Group confirms its forecasts for year 2008 : sales increase and growth in current operating income.

Boiron Group confirms its forecasts for year 2008 : sales increase and growth in current operating income. 2008 FIRST QUARTER ACTIVITY IFRS - In thousands of Euros 2007 2007 2008 constant France (1) 0,000 66,087 65,728-0.5% -0.5% Europe excluding France 0,000 33,221 41,346 +24.5% +23.2% North America 0,000

More information

Sponsorship Opportunities

Sponsorship Opportunities Sponsorship Opportunities Since ABC2 started Over the Edge for Brain Cancer we ve raised almost $1 million for brain cancer research! With our community partners and dedication of our participants we know

More information

Pasteur course MODELING OF INFECTIOUS DISEASES

Pasteur course MODELING OF INFECTIOUS DISEASES Pasteur course MODELING OF INFECTIOUS DISEASES PROGRAM 2017-2018 Modeling of Infectious Diseases 2017-2018 CO-DIRECTORS OF THE COURSE Pierre -Yves BOËLLE Université Pierre et Marie Curie Hôpital Saint

More information

ESEMeD/MHEDEA The European Study of the Epidemiology of Mental Disorders/Mental Health Disability : a

ESEMeD/MHEDEA The European Study of the Epidemiology of Mental Disorders/Mental Health Disability : a ESEMeD/MHEDEA 2000 - The European Study of the Epidemiology of Mental Disorders/Mental Health Disability : a European Assessment in the year 2000 (ESEMeD/MHEDEA 2000) Head : Kovess-Masfety Viviane, INSERM

More information

The SALVEO Study Improving mental health in the workplace

The SALVEO Study Improving mental health in the workplace The SALVEO Study Improving mental health in the workplace SALVEO is one of the largest studies on mental health conducted to date in Canada. It considers individual and organizational factors that contribute

More information

Preceptorship course in metastatic colorectal cancer management

Preceptorship course in metastatic colorectal cancer management SCIENTIFIC PROGRAMME Preceptorship course in metastatic colorectal cancer management, Centre Hépato-Biliaire General information Live educational preceptorship course dates The live educational preceptorship

More information

We re inventing the cancerology of tomorrow

We re inventing the cancerology of tomorrow We re inventing the cancerology of tomorrow UNICANCER GROUP OF THE FRENCH CANCER CENTRES Innovating together for patients UNICANCER unites all of the Cancer Centres in France: these private non-profit

More information

ECZEMA SOCIETY OF CANADA ATOPIC DERMATITIS: PATIENT INSIGHTS REPORT MILD-TO-MODERATE DISEASE

ECZEMA SOCIETY OF CANADA ATOPIC DERMATITIS: PATIENT INSIGHTS REPORT MILD-TO-MODERATE DISEASE ECZEMA SOCIETY OF CANADA ATOPIC DERMATITIS: PATIENT INSIGHTS REPORT MILD-TO-MODERATE DISEASE 1 OVERVIEW OF SURVEY RESULTS INTRODUCTION PATIENT INSIGHTS BY THE NUMBERS: Adult Atopic Dermatitis (AD) In the

More information

Tendon transfer for irreparable cuff tear

Tendon transfer for irreparable cuff tear Tendon transfer for irreparable cuff tear Springer Paris Berlin Heidelberg New York Hong Kong Londres Milan Tokyo Philippe Valenti Tendon transfer for irreparable cuff tear Philippe Valenti Orthopaedic

More information

7 November Buenos Aires, Argentina

7 November Buenos Aires, Argentina REGIONAL CONFERENCE FINAL PROGRAMME The Expert's view on growth hormone disorders 7 November 2016 - The Expert's view on growth hormone disorders Overview Growth hormone (GH) disorders are a wide range

More information

Masterclass. Mobidays. Skills Enhancement - Spine. Strasbourg, France April Institute

Masterclass. Mobidays. Skills Enhancement - Spine. Strasbourg, France April Institute Masterclass Mobidays Skills Enhancement - Spine Strasbourg, France 26-27 April 2018 Institute Masterclass: Mobidays Masterclass We know you are good. And we know you are eager to become even better. Get

More information

9 th World. Nephrology Conference. Sao Paulo, Brazil August 15-17, Theme: Latest advancements and new-fangled techniques in Nephrology

9 th World. Nephrology Conference. Sao Paulo, Brazil August 15-17, Theme: Latest advancements and new-fangled techniques in Nephrology Brochure 9 th World Nephrology Conference Sao Paulo, Brazil August 15-17, 2016 Theme: Latest advancements and new-fangled techniques in Nephrology Conference Secretariat 2360 Corporate Circle, Suite 400

More information

Entretiens d. Atopic dermatitis: What we see and what we don't. Entretiens d. 12 th Edition. th July

Entretiens d. Atopic dermatitis: What we see and what we don't. Entretiens d. 12 th Edition. th July FORMAT 210 X 148 MM Entretiens d 12 th Edition 5 2013 th July Entretiens d Atopic dermatitis: What we see and what we don't «Atopic Dermatitis: What We See and What We Don't» o12191-u5799-entretien avene.indd

More information

Patients as Partners Co-Creation in Health Care

Patients as Partners Co-Creation in Health Care Patients as Partners Co-Creation in Health Care Michael Bartl 1. Introduction Most of the time we discuss concepts like consumer centric-design, co-creation or open innovation in the context of business

More information

Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives. Oncology Therapeutic Area Janssen Research & Development, LLC

Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives. Oncology Therapeutic Area Janssen Research & Development, LLC Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives Oncology Therapeutic Area Janssen Research & Development, LLC The patients are waiting. Dr. Paul Janssen To Our Potential

More information

Preliminary programme. Masterclass. Mobidays. Skills Enhancement - Spine. Strasbourg, France December Institute

Preliminary programme. Masterclass. Mobidays. Skills Enhancement - Spine. Strasbourg, France December Institute Preliminary programme Masterclass Mobidays Skills Enhancement - Spine Strasbourg, France 13-14 December 2018 Institute Masterclass: Mobidays Masterclass We know you are good. And we know you are eager

More information

WHF Salim Yusuf Emerging Leaders Programme

WHF Salim Yusuf Emerging Leaders Programme WHF Salim Yusuf Emerging Leaders Programme Empowering the next generation of leaders to shape the future of cardiovascular health www.whfel.org Investing in the CVD leadership of the future The World Heart

More information

CANDIDATE PACK. Trustee

CANDIDATE PACK. Trustee CANDIDATE PACK Trustee Candidate Pack 2014 Background Information Introduction The Motor Neurone Disease (MND) Association is the only national charity in England, Wales and Northern Ireland that funds

More information

Gavi Risk Appetite Statement Version 2.0

Gavi Risk Appetite Statement Version 2.0 Gavi Risk Appetite Statement Version 2.0 DOCUMENT ADMINISTRATION VERSION NUMBER 1.0 2.0 APPROVAL PROCESS Reviewed and recommended by: Gavi Programme & Policy Committee Reviewed and approved by: Gavi, the

More information

Neurofibromatosis (NF) Center

Neurofibromatosis (NF) Center Washington University Neurofibromatosis (NF) Center THE NF CENTER: EXCEPTIONAL CARE THROUGH GROUNDBREAKING RESEARCH An international leader in research and treatment of neurofibromatosis (NF), the Washington

More information

Health and citizenship education: What preventions? What solidarities?

Health and citizenship education: What preventions? What solidarities? Health and citizenship education: What preventions? What solidarities? 7th international conference of the UNIRéS network 10th & 11th October 2018 MGEN 3, Square Max Hymans 75 015 Paris Further information

More information

DEPRESSION QUESTIONS, ANSWERS AND SOLUTIONS

DEPRESSION QUESTIONS, ANSWERS AND SOLUTIONS DEPRESSION QUESTIONS, ANSWERS AND SOLUTIONS ON THE PATH TO RECOVERY How this booklet can help This booklet will help you and your family better understand your medical condition and its treatment. Specifically,

More information

Table Of Content. The European Influenza Surveillance Scheme... 2 Summary... 3 Coordinator, Leader contact and partners Outputs...

Table Of Content. The European Influenza Surveillance Scheme... 2 Summary... 3 Coordinator, Leader contact and partners Outputs... Table Of Content The European Influenza Surveillance Scheme... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Institut Pasteur... 6 Health Division... 6 Nphs Communicable Disease Surveillance

More information

GENODERMATOSES NETWORK

GENODERMATOSES NETWORK FRT - FONDATION RENE TOURAINE GENODERMATOSES NETWORK www.genodermatoses-network.org 2003 until today.. Prof. Christine Bodemer President of the Genodermatoses Network Scientific Committee Head of the Department

More information

Allergies. and their diagnosis

Allergies. and their diagnosis Allergies and their diagnosis What are allergies? Allergies are very common in Australia and they are on the increase in both adults and children. About one in three people will be affected at some time

More information

Developing the next generation of infection and immunity leaders. The Peter Doherty Institute for Infection and Immunity

Developing the next generation of infection and immunity leaders. The Peter Doherty Institute for Infection and Immunity Developing the next generation of infection and immunity leaders The Peter Doherty Institute for Infection and Immunity Nobody can decide to discover something, but there are ways of making a discovery

More information

Novan Announces Promising Clinical Results with SB414

Novan Announces Promising Clinical Results with SB414 Novan Announces Promising Clinical Results with SB414 In the recently completed Phase 1b trial for atopic dermatitis, clinical efficacy measures were highly correlated with critical and disease-relevant

More information

Cutaneous lymphomas: a challenge for the pathologist and the clinician

Cutaneous lymphomas: a challenge for the pathologist and the clinician Cutaneous lymphomas: a challenge for the pathologist and the clinician In retrospect: 30 years of lymphoma research in dermatology Zurich, 16 February 2006, 10:00 17:00 University Hospital Zurich UniversitätsSpital

More information

PRELIMINARY PROGRAMME. 2nd European-Middle East Forum on Managing cardiovascular risk factors in clinical practice 6 December, Istanbul, Turkey

PRELIMINARY PROGRAMME. 2nd European-Middle East Forum on Managing cardiovascular risk factors in clinical practice 6 December, Istanbul, Turkey PRELIMINARY PROGRAMME 2nd European-Middle East Forum on Managing cardiovascular risk factors in clinical practice 6 December, 2013 - Istanbul, Turkey Background and aims of the conference Cardiovascular

More information

TOGETHER AGAINST GENODERMATOSES TRAINING & NETWORKING SESSION

TOGETHER AGAINST GENODERMATOSES TRAINING & NETWORKING SESSION TOGETHER AGAINST GENODERMATOSES TRAINING & NETWORKING SESSION Smallville Hotel, Beirut, Lebanon 6-7 November 2014 WELCOME MESSAGE Dear Friends and Colleagues, It is our great pleasure to invite you to

More information

PRESS KIT LIVING TOGETHER BETTER SOMFY CORPORATE FOUNDATION

PRESS KIT LIVING TOGETHER BETTER SOMFY CORPORATE FOUNDATION PRESS KIT LIVING TOGETHER BETTER SOMFY CORPORATE FOUNDATION LIVING TOGETHER BETTER: THE MISSION OF THE SOMFY FOUNDATION In choosing the fight for inadequate housing as its field of action, the Somfy Foundation

More information

CME Tour on clinical diabetes management PRELIMINARY PROGRAM

CME Tour on clinical diabetes management PRELIMINARY PROGRAM PRELIMINARY PROGRAM CME Tour on clinical diabetes management 28 October, 2013 - Kampala, Uganda 30 October, 2013 - Nairobi, Kenya 1 November, 2013 - Windhoek, Namibia CME Tour on clinical diabetes management

More information

5-6 June University of Pisa, Italy

5-6 June University of Pisa, Italy SCIENTIFIC PROGRAMME International School of Thyroid Ultrasonography 5-6 June 2015 - University of Pisa, Italy General information Venue This live educational course takes place at the: University of

More information

PATHWAY TO STOP DIABETES

PATHWAY TO STOP DIABETES PATHWAY TO STOP DIABETES Corporate Benefits & Recognition Opportunities Pathway to Stop Diabetes Corporate Benefits & Recognition Opportunities To sustain and grow this successful initiative, we need partners

More information

PrEP provision in healthcare settings: UK and France

PrEP provision in healthcare settings: UK and France PrEP provision in healthcare settings: UK and France Dr Michael Brady Kings College Hospital Terrence Higgins Trust London Content How to integrate PrEP provision into: Sexual health services General health

More information

Testimonials from. our specialists and patients

Testimonials from. our specialists and patients Testimonials from our specialists and patients AT THE HEART OF THE AVÈNE HYDROTHERAPY CENTER Pure, sheltered, protected water in the heart of the Haut-Languedoc Nature Park, whose unique, invariable

More information

CORPORATE MEMBER PLAN An long term alliance to find the cure for leukaemia, a seal of social commitment.

CORPORATE MEMBER PLAN An long term alliance to find the cure for leukaemia, a seal of social commitment. CORPORATE MEMBER PLAN 2011 An long term alliance to find the cure for leukaemia, a seal of social commitment. Who are we? I always thought that if there was one chance in a million, then it would be mine

More information

BJD. Summary. British Journal of Dermatology CLINICAL AND LABORATORY INVESTIGATIONS

BJD. Summary. British Journal of Dermatology CLINICAL AND LABORATORY INVESTIGATIONS CLINICAL AND LABORATORY INVESTIGATIONS BJD British Journal of Dermatology Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency H. Aubert-Wastiaux, L. Moret,*

More information

Research Collaborations: Lessons from PeDRA and the SPD

Research Collaborations: Lessons from PeDRA and the SPD Research Collaborations: Lessons from PeDRA and the SPD Amy Paller, MD Professor and Chair, Dermatology Professor, Pediatrics Northwestern Univ. Feinberg School of Medicine Chicago, IL No conflicts of

More information

CORPORATE RESPONSIBILITY

CORPORATE RESPONSIBILITY CORPORATE RESPONSIBILITY Passionate about our work, responsible in our actions ABBVI E B Employees volunteer to deliver the AbbVie Foundation s science and engineering programs to students, shown here

More information

Letter from the CEO. Dear Friends of IAVI,

Letter from the CEO. Dear Friends of IAVI, IAVI Annual Report 2017 Letter from the CEO Dear Friends of IAVI, We are pleased to present an overview of the progress IAVI and partners have made in 2017 toward our pursuit of the development of vaccines

More information

Press Release. The key findings from the research were:

Press Release. The key findings from the research were: Press Release Sanofi and NRAS launch RefRAme the Future campaign to highlight the importance of mental strength in helping people with rheumatoid arthritis (RA) better manage their condition New campaign

More information

ABOUT US 7/3/2017 CORPORATE PROFILE 1

ABOUT US 7/3/2017 CORPORATE PROFILE 1 CORPORATE PROFILE ABOUT US STEMCELL MANILA brings Cutting Edge Technology & Breakthrough Equipment at its MIMMO Regenerative Medical Centre, Suite 2104 Centuria Medical Makati, Barangay Poblacion, Makati,

More information

Patient First. Aneurin Bevan University Health Board. Personal Responsibility. Values and Behaviours Framework. Passion for Improvement

Patient First. Aneurin Bevan University Health Board. Personal Responsibility. Values and Behaviours Framework. Passion for Improvement Patient First Personal Responsibility Aneurin Bevan University Health Board Passion for Improvement Values and Behaviours Framework Pride in What We Do Staff Information leaflet Why do we need a values

More information

Volunteer Orientation

Volunteer Orientation Volunteer Orientation Our Mission Olive Crest is dedicated to Preventing child abuse, to Treating and Educating at-risk children and to Preserving the family One Life at a Time. Importance of Volunteering

More information

The corporate responsibility for health in society

The corporate responsibility for health in society The corporate responsibility for health in society 20 May 2010 The corporate responsibility for health in society Lars Rebien Sørensen CEO & President Novo Nordisk A/S The corporate responsibility for

More information

SECTION 3: WHAT DOES DIABETES UK DO?

SECTION 3: WHAT DOES DIABETES UK DO? SECTION 3: WHAT DOES DIABETES UK DO? By volunteering with us you re helping Diabetes UK tackle the diabetes crisis. This section will explain what we are doing to achieve this, the role volunteers play

More information

Low-intensity ultrasound (Exogen TM ) for the treatment of fractures

Low-intensity ultrasound (Exogen TM ) for the treatment of fractures Low-intensity ultrasound (Exogen TM ) for the treatment of fractures SUMMARY AGENCE D ÉVALUATION DES TECHNOLOGIES ET DES MODES D INTERVENTION EN SANTÉ Low-intensity ultrasound (Exogen TM ) for the treatment

More information

4 th International Workshop on Diagnostic and Interventional Prostate MRI April 2019, Thursday 11 th and Friday 12 th, Paris, France

4 th International Workshop on Diagnostic and Interventional Prostate MRI April 2019, Thursday 11 th and Friday 12 th, Paris, France Organization : François Cornud, M.D., Hôpital Cochin, Department of Radiology (Pr Legmann), Course format Teaching course program of Paris Descartes University on Prostate MRI Lectures (40%) and hands-on

More information

Addressing NCDs: Psoriasis and its Co-morbidities

Addressing NCDs: Psoriasis and its Co-morbidities Addressing NCDs: Psoriasis and its Co-morbidities fotolia SHARED OPPORTUNITIES FOR ACTION Introduction Noncommunicable diseases (NCDs) are now widely recognized as a major challenge to health and sustainable

More information

Part 2 of our 3 part series! Making MEDS Work for You

Part 2 of our 3 part series! Making MEDS Work for You Part 2 of our 3 part series! 2 Making MEDS Work for You Table of Contents 3 Introduction 4 Is there a cure for HIV/AIDS? How HIV medications keep HIV from making copies 5 How do antiretrovirals work? 6

More information

The Smokefree Class Competition What is it about?

The Smokefree Class Competition What is it about? The Smokefree Class Competition What is it about? a universal smoking prevention programme for pupils aged 11-14 years. The main aims are to delay or prevent the onset of smoking to motivate adolescents

More information

DIVERSITY IN EDUCATION

DIVERSITY IN EDUCATION REPORT 2016 DIVERSITY IN EDUCATION We are often asked whether there is a common theme to the charitable work that our family Foundation has been involved in for over thirty years. Given the many diverse

More information

Committee of the Whole Report For the Meeting of August 18, 2016

Committee of the Whole Report For the Meeting of August 18, 2016 CITY OF VICTORIA For the Meeting of To: Committee of the Whole Date: August 18,2016 From: Subject: Paul Bruce, Fire Chief RECOMMENDATION That Council receive this report for information relating to the

More information

Quantification of Demodex folliculorum by PCR in rosacea and its relationship to skin innate immune activation

Quantification of Demodex folliculorum by PCR in rosacea and its relationship to skin innate immune activation DOI: 10.1111/exd.12030 www.blackwellpublishing.com/exd Original Article Quantification of Demodex folliculorum by PCR in rosacea and its relationship to skin innate immune activation Christiane Casas 1,CarlePaul

More information

The Burden of Atopic Dermatitis: from Population to Bedside

The Burden of Atopic Dermatitis: from Population to Bedside The Burden of Atopic Dermatitis: from Population to Bedside S028 AAD Annual Meeting March 2, 2019 Research and institutional funding Sanofi Regeneron Disclosures Consultant Honoraria Sanofi Astellas Canada

More information

The ESSKA Paediatric Anterior Cruciate Ligament Monitoring Initiative (PAMI)

The ESSKA Paediatric Anterior Cruciate Ligament Monitoring Initiative (PAMI) The ESSKA Paediatric Anterior Cruciate Ligament Monitoring Initiative (PAMI) Matteo Denti ESSKA President Romain Seil ESSKA 1st Vice-President Introduction The initiative Paediatric ACL injuries are rare

More information

Report from the visiting committee

Report from the visiting committee Section des Unités de recherche Report from the visiting committee Research unit : Groupe de recherche sur les maladies infectieuses et inflammatoires (GRII) University of Réunion February 2008 Section

More information

3rd Human Cancer Immunology Course for Oncologists and Scientists A course for Clinicians and Investigators

3rd Human Cancer Immunology Course for Oncologists and Scientists A course for Clinicians and Investigators Service de Médecine & Laboratoire d Investigation Clinique & d Oncologie Expérimentale : Pr Martine J. PICCART, Chef du Service de Médecine Centre des Tumeurs de l Université Libre de Bruxelles Tél. :

More information

Council of the European Union Brussels, 28 October 2015 (OR. en)

Council of the European Union Brussels, 28 October 2015 (OR. en) Conseil UE Council of the European Union Brussels, 28 October 2015 (OR. en) PUBLIC 13261/15 LIMITE SAN 347 NOTE From: To: Subject: General Secretariat of the Council Working Party on Public Health Draft

More information

Section des Unités de recherche. Evaluation report. Research unit : Hepatitis C Virology. University Paris 5

Section des Unités de recherche. Evaluation report. Research unit : Hepatitis C Virology. University Paris 5 Section des Unités de recherche Evaluation report Research unit : Hepatitis C Virology University Paris 5 February 2009 Section des Unités de recherche Evaluation report Research unit : Hepatitis C Virology

More information

Ways to Wellbeing. Social Prescribing Programme. Social Impact Report Report produced by:

Ways to Wellbeing. Social Prescribing Programme. Social Impact Report Report produced by: Ways to Wellbeing Social Prescribing Programme Social Impact Report 2016-2017 Report produced by: Who We Are Wellbeing Enterprises CIC is an award winning social enterprise recognised for its innovative

More information

The Team Approach to Hospice Palliative Care: Integration of Formal and Informal Care at End of Life

The Team Approach to Hospice Palliative Care: Integration of Formal and Informal Care at End of Life The Team Approach to Hospice Palliative Care: Integration of Formal and Informal Care at End of Life December 2004 Malcolm Anderson Karen Parent Supported by: Canadian Health Services Research Foundation

More information

Culture and ethics of care for mental illness

Culture and ethics of care for mental illness Culture and ethics of care for mental illness Nouzha Guessous (Morocco) Researcher and Consultant in Bioethics and Human Rights Former chair of the UNESCO International Bioethics Committee (2005-2007)

More information

International Women s Day.

International Women s Day. It s time to unleash the full potential of women http://rwanda.unfpa.org International Women s Day. Celebrating 100 years of Women s achievement 8 March 2011 Message of Dr. Babatunde Osotimehin UNFPA Executive

More information

American Thyroid Association

American Thyroid Association American Thyroid Association CASE FOR SUPPORT LEADING THE WAY UNDERSTANDING, PREVENTING, DIAGNOSING, AND TREATING THYROID DISEASE 2 AMERICAN THYROID ASSOCIATION A CASE FOR SUPPORT A butterfly shaped gland

More information

Research units. Université Toulouse 3 - Paul Sabatier - UPS Centre National de la Recherche Scientifique - CNRS

Research units. Université Toulouse 3 - Paul Sabatier - UPS Centre National de la Recherche Scientifique - CNRS Research units HCERES report on research unit: Research Center on Animal Cognition CRCA Under the supervision of the following institutions and research bodies: Université Toulouse 3 - Paul Sabatier -

More information

Ambitious Futures 2020 Strategy

Ambitious Futures 2020 Strategy Ambitious Futures 2020 Strategy About us Our vision A world where the ordinary is the everyday experience of children and young people with autism. Ambitious about Autism is the national charity for children

More information

A World of Hyperpigmentary Disorders

A World of Hyperpigmentary Disorders AVENE 11EME ENTRETIENS_Mise en page 1 10/10/12 11:14 Page1 A World of Hyperpigmentary Disorders Chairman : Prof. Jean-Paul ORTONNE (Nice, France) 11 èmes Entretiens d'avène Station thermale d'avène, 19

More information

Master of Science in Management: Fall 2017 and Spring 2018

Master of Science in Management: Fall 2017 and Spring 2018 Master of Science in Management: Fall 2017 and Spring 2018 2 - Required Professional Development & Career Workshops MGMT 7770 Prof. Development Workshop 1/Career Workshops (Fall) Wed. 9am, 12pm & 3pm MGMT

More information

*APHP: Hôpital Beaujon Professor P Bedossa, Dr F Degos, Professor P Marcellin, Professor

*APHP: Hôpital Beaujon Professor P Bedossa, Dr F Degos, Professor P Marcellin, Professor APPENDIX 1 LIST OF COINVESTIGATORS *APHP: Hôpital Beaujon Professor P Bedossa, Dr F Degos, Professor P Marcellin, Professor M Vidaud; Hôpital Cochin-Necker: Professor S Pol, Professor Ph Sogni, Professor

More information

Childhood cancer s enemy in the Philippines is called Doc Mae

Childhood cancer s enemy in the Philippines is called Doc Mae Published on Sandoz (https://www.sandoz.com) Home > Printer-friendly PDF > Childhood cancer s enemy in the Philippines is called Doc Mae Childhood cancer s enemy in the Philippines is called Doc Mae Access

More information

MBA - EXECUTIVE MASTERS - ADVANCED, SHORT & ACCELERATED PROGRAMMES - TAILOR-MADE SOLUTIONS

MBA - EXECUTIVE MASTERS - ADVANCED, SHORT & ACCELERATED PROGRAMMES - TAILOR-MADE SOLUTIONS www.solvay.edu MBA - EXECUTIVE MASTERS - ADVANCED, SHORT & ACCELERATED PROGRAMMES - TAILOR-MADE SOLUTIONS At www.solvay.edu, watch videos, Stay connected! 2 Solvay Executive Education How far will you

More information

Active Tourism Cluster

Active Tourism Cluster Active Tourism Cluster Active Tourism Cluster basic information The Active Tourism Cluster is a platform of voluntary cooperation between enterprises, research units, business environment institutions,

More information

Master of Science in Management: Fall 2018 and Spring 2019

Master of Science in Management: Fall 2018 and Spring 2019 Master of Science in Management: Fall 2018 and Spring 2019 2 - Required Professional Development & Career Workshops MGMT 7770 Prof. Development Workshop 1/Career Workshops (Fall) Wed. 9am, 12pm & 3pm MGMT

More information

The M8 Alliance Declaration. World Health Summit 2016 (Version: 07/10/ :30)

The M8 Alliance Declaration. World Health Summit 2016 (Version: 07/10/ :30) World Health Summit 2016 (Version: 07/10/2016-20:30) This year's World Health Summit (WHS) took place in a political context of great hope and serious alarm. Immense strides were made at the UN General

More information

Ineligible Participants and Those Who Terminate Participation Early

Ineligible Participants and Those Who Terminate Participation Early 2013 Perceptions & Insights Study Report on Ineligible Participants and Those Who Terminate Participation Early Although a large and growing body of research has looked at a variety of participant experiences

More information

African Americans and Clinical Research

African Americans and Clinical Research African Americans and Clinical Research If you have ever taken a pill or been treated for an illness, you have seen the benefit of clinical trials. Each year, thousands of African Americans take part in

More information